ArticleJournal for immunotherapy of cancer2020

CD25-targeted antibody-drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity.

Francesca Zammarchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.